Zealand Pharma A/S Cash Flow Reinvestment Rate
Zealand Pharma A/S cash flow reinvestment rate. Zealand Pharma A/S (ZEAL) has a Cash Flow Reinvestment Rate of 0.19x as of June 2025, reinvesting Dkr1.58 Billion (capex Dkr6.73 Million plus investments Dkr-1.57 Billion) from operating cash flow of Dkr8.52 Billion. Explore ZEAL operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zealand Pharma A/S (2012–2025)
Cash flow reinvestment rate of Zealand Pharma A/S from 2012 to 2025. Historical reinvestment intensity for Zealand Pharma A/S across 3 annual periods. Explore ZEAL capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Zealand Pharma A/S Cash Flow Reinvestment Rate by Year (2012–2025)
Zealand Pharma A/S cash flow reinvestment rate by year from 2012 to 2025. Year-by-year capital reinvestment analysis for Zealand Pharma A/S. For the full cash flow conversion analysis, see cash flow conversion of Zealand Pharma A/S.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | Dkr33.37 Million | Dkr6.53 Billion | Dkr33.37 Million | ▼ -99.9% |
| 2016 | 7.40x | Dkr302.56 Million | Dkr40.90 Million | Dkr2.60 Million | ▲ +5628.9% |
| 2012 | 0.13x | Dkr8.85 Million | Dkr68.54 Million | Dkr8.85 Million | — |